Committee for Medicinal Products for Human Use (CHMP): 20-23 July 2026, European Medicines Agency, Amsterdam, the Netherlands, from 20 July 2026 to 23 July 2026

Submitted by Anonymous (not verified) on 8 October 2026 - 12:35

Committee for Medicinal Products for Human Use (CHMP): 20-23 July 2026, European Medicines Agency, Amsterdam, the Netherlands, from 20 July 2026 to 23 July 2026

Committee for Medicinal Products for Human Use (CHMP): 20-23 April 2026, European Medicines Agency, Amsterdam, the Netherlands, from 20 April 2026 to 23 April 2026

Submitted by Anonymous (not verified) on 8 October 2026 - 12:31

Committee for Medicinal Products for Human Use (CHMP): 20-23 April 2026, European Medicines Agency, Amsterdam, the Netherlands, from 20 April 2026 to 23 April 2026

Human medicines European public assessment report (EPAR): Tepmetko, tepotinib, Date of authorisation: 16/02/2022, Revision: 6, Status: Authorised

Submitted by Anonymous (not verified) on 8 October 2026 - 12:16

Human medicines European public assessment report (EPAR): Tepmetko, tepotinib, Date of authorisation: 16/02/2022, Revision: 6, Status: Authorised

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More
randomness